Real-Time PCR for Quantitative Detection of Bovine Parvovirus during Manufacture of Biologics |
Lee, Dong-Hyuck
(Department of Biological Sciences, Hannam University)
Lee, Jung-Hee (Department of Biological Sciences, Hannam University) Kim, Chan-Kyong (Department of Biological Sciences, Hannam University) Kim, Tae-Eun (Department of Biological Sciences, Hannam University) Bae, Jung-Eun (Department of Biological Sciences, Hannam University) Kim, In-Seop (Department of Biological Sciences, Hannam University) |
1 | Adamson, S. R. 1999. Experiences of virus, retrovirus and retrovirus-like particles in chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics. Dev. Biol. Stand. 93: 89-96 |
2 | Barnes, M. A., R. E. Wright, A. B. Bodine, and C. F. Alberty. 1982. Frequency of bluetongue and bovine parvovirus infection in cattle in South Carolina dairy herds. Am. J. Vet. Res. 43: 1078-1080 PUBMED |
3 | Celis, P. and G. Silvester. 2004. European regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products. Dev. Biol. Stand. 118: 3-10 |
4 | Code of federal regulation 9 (9CFR), animal and animal products. 1996. part 113.53. Requirement for ingredients of animal origin used for production of biologics |
5 | Jennings, A. 1999. Detecting viruses in sera: methods used and their merits. Dev. Biol. Stand. 99: 51-59 PUBMED |
6 | Ryu, S.-R., J.-H. Shin, S.-Y. Baek, J.-O. Kim, K.-I. Min, B.- S. Min, B.-G. Kim, D.-K. Kim, M.-K. Park, M.-J. Ahn, K.- S. Chae, H.-S. Jeong, S.-H. Lee, and S.-N. Park. 2003. Evaluation of limit of detection and range of quantitation for RT-PCR, real-time RT-PCR and RT-PCR-ELISA detection of bovine viral diarrhea virus contamination in biologics derived from cell cultures. J. Bacteriol. Virol. 33: 161-168 |
7 | Storz, J. and R. C. Bates. 1973. Parvovirus infection in calves. J. Am. Vet. Med. Assoc. 163: 884-886 |
8 | Belak, S. 2007. Molecular diagnosis of viral diseases, present trends and future aspects: A view from the OIE collaborating centre for the application of polymerase chain reaction methods for diagnosis of viral diseases in veterinary medicine. Vaccine 25: 5444-5452 DOI ScienceOn |
9 | Parkman, P. D. 1996. Safety of biopharmaceuticals: a current perspective. Dev. Biol. Stand. 88: 5-7 PUBMED |
10 | Merten, O.-W. 2002. Virus contamination of cell cultures-a biotechnological view. Cytotechnol. 39: 91-116 DOI ScienceOn |
11 | Chen, K. C., B. C. Shull, E. A. Moses, M. Lederman, E. R. Stout, and R. C. Bates. 1986. Complete nucleotide sequence and genome organization of bovine parvovirus. J. Virol. 60: 1085-1097 |
12 | Cho, H. M., D. H. Lee, H. M. Kim, and I. S. Kim. 2008. Real-time RT-PCR for quantitative detection of bovine viral diarrhoea virus during manufacture of biologics. Kor. J. Microbiol. Biotechnol. 36: 34-42 과학기술학회마을 |
13 | Garnick, R. L. 1998. Raw materials as a source of contamination in large-scale cell culture. Dev. Biol. Stand. 93: 21-29 PUBMED |
14 | Belak, S. and P. Thoren. 2001. Molecular diagnosis of animal diseases: some experiences over the past decade. Expert Rev. Mol. Diagn. 1: 434-443 DOI ScienceOn |
15 | Lee, D. H., H. S. Jeong, J. H. Lee, T. E. Kim, J. Lee, and I. S. Kim. 2008. Real-time PCR for quantitative detection of bovine herpesvirus type 1. Kor. J. Microbiol. 44: 14-21 과학기술학회마을 |
16 | Erickson, G. A., S. R. Bolin, and J. G. Landgraf. 1991. Viral contamination of fetal bovine serum used for tissue culture: risks and concerns. Dev. Biol. Stand. 75: 173-175 PUBMED |
17 | Kil, T. G., W. J. Kim, D. H. Lee, Y. Kang, H. M. Sung, S. H. Yoo, S.-N. Park, and I. S. Kim. 2005. Quantitative real-time PCR of porcine parvovirus as a model virus for cleaning validation of chromatography during manufacture of plasma derivatives. Kor. J. Microbiol. 41: 216-224 과학기술학회마을 |
18 | Gajiwala, K. and A. L. Gajiwala. 2004. Evaluation of lyophilised, gamma-irradiated amnion as a biological dressing. Cell Tissue Bank. 5: 73-80 DOI |
19 | Yarlagadda, P. K., M. Chandrasekharan, and J. Y. Shyan. 2005. Recent advances and current developments in tissue scaffolding. Biomed. Mater. Eng. 15: 159-177 PUBMED |
20 | Jeong, H.-S., J,-H. Shin, Y.-N. Park, J.-Y. Choi, Y.-L. Kim, B.-G. Kim, S.-R. Ryu, S.-Y. Baek, S.-H. Lee, and S.-N. Park. 2003. Development of real-time RT-PCR for evaluation of JEV clearance during purification of HPV type 16 L1 virus-like particles. Biologicals 31: 223-229 DOI ScienceOn |
21 | Rudnick, A. 2006. Advances in tissue engineering and use of type 1 bovine collagen particles in wound bed preparation. J. Wound Care 15: 402-404 DOI PUBMED |
22 | Horaud, F. 1991. Introductory remark: viral safety of biologicals. Dev. Biol. Stand. 75: 3-7 PUBMED |
23 | Choi, Y.-M., J.-K. Kim, J.-I. Park, and S.-W. Jeong. 2006. Evaluation of bovine amniotic membrane for the treatment of superficial canine corneal ulcer. J. Vet. Clinics 23: 334-336 과학기술학회마을 |
24 | Lee, D. H., H. M. Cho, H. M. Kim, J. Lee, and I. S. Kim. 2008. Real-time PCR for validation of minute virus of mice safety during the manufacture of mammalian cell culture-derived biopharmaceuticals. Kor. J. Microbiol. Biotechnol. 36: 12-20 과학기술학회마을 |
25 | Faraj, K. A., T. H. van Kuppevelt, and W. F. Daamen. 2007. Construction of collagen scaffolds that mimic the three-dimensional architecture of specific tissues. Tissue Eng. 13: 2387-2394 DOI ScienceOn |
26 | International Conference on Harmonisation. 1998. Guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability. Federal Resister 63: 51074-51084 |
27 | Sandals, W. C. D., R. C. Povey, and A. H. Meek. 1995. Prevalence of bovine parvovirus infection in Ontario dairy cattle. Can. J. Vet. Res. 59: 81-86 |
28 | Storz, J., S. Young, E. J. Carroll, R. C. Bates, R. A. Bowen, and D. A. Keney. 1978. Parvovirus infection of the bovine fetus: Distribution of infection, antibody response, and agerelated susceptibility. Am. J. Vet. Res. 39: 1099-1102 PUBMED |
29 | Watzinger, F., K. Ebner, and T. Lion. 2006. Detection and monitoring of virus infections by real-time PCR. Mol. Aspects Med. 27: 254-298 DOI ScienceOn |
30 | Darling, A. 2002. Validation of biopharmaceutical purification process for virus clearance evaluation. Mol. Biotechnol. 21: 57-83 DOI ScienceOn |
31 | Schneider, G. 2003. Bioimplants-characteristics and use. Laryngorhinootologie 82: 839-852 DOI ScienceOn |